Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas.

Filopanti, M; Barbieri, A M; Angioni, A R; Colao, A; Gasco, V; Grottoli, S; Peri, A; Baglioni, S; Fustini, M F; Pigliaru, F; Monte, P D; Borretta, G; Ambrosi, B; Jaffrain-Rea, M L; Gasperi, M; Brogioni, S; Cannavò, S; Mantovani, G; Beck-Peccoz, P; Lania, A; Spada, A

Filopanti, M; Barbieri, A M; Angioni, A R; Colao, A; Gasco, V; Grottoli, S; Peri, A; Baglioni, S; Fustini, M F; Pigliaru, F; Monte, P D; Borretta, G; Ambrosi, B; Jaffrain-Rea, M L; Gasperi, M; Brogioni, S; Cannavò, S; Mantovani, G; Beck-Peccoz, P; Lania, A; Spada, A.

Affiliation

Filopanti M; Department of Medical Sciences, University of Milan, Endocrine and Diabetes Unit Fondazione Ospedale Maggiore IRCCS, Milan, Italy.

Pharmacogenomics J ; 8(5): 357-63, 2008 Oct.

Article in En | MEDLINE | ID: mdl-18332900

Subject(s)

Adenoma/drug therapy; Dopamine Agonists/therapeutic use; Ergolines/therapeutic use; Pituitary Neoplasms/drug therapy; Polymorphism, Genetic; Prolactin/metabolism; Receptors, Dopamine D2/genetics; Adenoma/genetics; Adenoma/metabolism; Adult; Alleles; Cabergoline; Cross-Sectional Studies; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Pituitary Neoplasms/genetics; Pituitary Neoplasms/metabolism; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Polymorphism, Genetic / Prolactin / Adenoma / Receptors, Dopamine D2 / Dopamine Agonists / Ergolines Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics J Year: 2008 Document type: Article

Fulltext

XML

PubMed Links

Search on Google